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A B S T R A C T   
The structural diversity of the lipopolysaccharides (LPSs) from Helicobacter pylori poses a challenge to establish 
accurate and strain-specific structure-function relationships in interactions with the host. Here, LPS structural 
domains from five clinical isolates were obtained and compared with the reference strain 26695. This was 
achieved combining information from structural analysis (GC-MS and ESI-MSn) with binding data after inter-
rogation of a LPS-derived carbohydrate microarray with sequence-specific proteins. All LPSs expressed Lewisx/y 
and N-acetyllactosamine determinants. Ribans were also detected in LPSs from all clinical isolates, allowing their 
distinction from the 26695 LPS. There was evidence for 1,3-D-galactans and blood group H-type 2 sequences in 
two of the clinical isolates, the latter not yet described for H. pylori LPS. Furthermore, carbohydrate microarray 
analyses showed a strain-associated LPS recognition by the immune lectins DC-SIGN and galectin-3 and revealed 
distinctive LPS binding patterns by IgG antibodies in the serum from H. pylori-infected patients.   
1. Introduction 
Helicobacter pylori is a pathogenic Gram-negative bacterium that 
colonizes the human stomach of about 50 % of world’s population (Hooi 
et al., 2017). Persistent infections often lead to several gastric diseases, 
ranging from chronic gastritis to gastric carcinoma (Parreira, Duarte, 
Reis, & Martins, 2016). It is well established that carbohydrates (gly-
cans) play a pivotal role in host-H. pylori interactions. On the one hand, 
the adherence of bacteria to the gastric mucosa, which promotes initial 
attachment and persistence, is mediated by bacterial adhesins that 
target host glycans (Magalhães & Reis, 2010). On the other hand, lipo-
polysaccharides (LPSs), the major components of the bacterial outer 
membrane, act as pathogen-associated molecular patterns for pathogen 
recognition receptors expressed on host cells, with the ability to 
modulate and to trigger immune responses (Müller, Oertli, & Arnold, 
2011). 
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The structure of LPS encompasses a lipid A and a core oligosaccha-
ride (OS) domain, which are conserved within a species, and a long 
chain repeat-unit polysaccharide termed O-antigen (O-chain), with a 
remarkable structural diversity. LPSs can occur with or without O-an-
tigen chains, being termed smooth- or rough-LPSs, respectively (Fer-
reira, Silva, Monteiro, & Coimbra, 2012). A unique feature of the 
O-chain of the LPSs of most H. pylori strains is the expression of Lewis 
(Le) antigens, mimicking those of gastric epithelium (Monteiro, 2001). 
This camouflage assists bacteria to escape from host’s immune responses 
and may also induce autoimmune disorders, contributing to the severity 
and chronicity of infection (Moran & Prendergast, 2001). 
Earlier structural and immunological studies established that the 
core OS of H. pylori LPS comprises an inner and outer core (Ferreira 
et al., 2012). More recently, a redefinition of H. pylori LPS has proposed 
(i) the core OS as a short conserved hexasaccharide without the ca-
nonical inner and outer core architecture; and (ii) the O-antigen 
composed of epitopes previously assigned to the outer core OS, namely a 
conserved trisaccharide (Trio), the variable glucan and heptan, identi-
fied in many H. pylori strains, followed by the well-established N-ace-
tyllactosamine (LacNAc) and Le antigens (Fig. 1) (Li et al., 2017). Other 
glycan components, such as ribans (Altman, Chandan, Li, & Vinogradov, 
2011), mannans (Ferreira, Azevedo et al., 2010) and amylose-like gly-
cans (Ferreira et al., 2009) have also been identified for some H. pylori 
strains. 
This notable structural diversity of H. pylori LPS often hampers the 
establishment of accurate and strain-specific structure-function re-
lationships in interactions with the host. Thus, structural studies of LPS 
from different H. pylori strains, as well as their recognition by host 
proteins, would contribute to a better understanding of their molecular 
complexity and role in pathogenesis. 
Microarrays of sequence-defined glycans are powerful tools to 
address the specificity of carbohydrate recognition systems and eluci-
date carbohydrate structures involved both in endogenous biological 
processes and interactions with microbes. Since the first proof-of- 
concept studies (Blixt et al., 2004; Fukui, Feizi, Galustian, Lawson, & 
Chai, 2002; Wang, Liu, Trummer, Deng, & Wang, 2002), various 
microarray platforms have been constructed and different glycan li-
braries assembled with the aim of answering different biological ques-
tions (Li et al., 2018; Manimala, Roach, Li, & Gildersleeve, 2006; Palma 
et al., 2015; Song et al., 2011; Wu et al., 2019; Zong et al., 2017). 
Although most of the glycan probe libraries are of mammalian type, the 
glycan repertoire is increasing in number and diversity, particularly to 
cover microbe-derived structures, in the form of sequence-defined bac-
terial fragments (Geissner et al., 2019; Stowell et al., 2014), as well as 
bacterial PS (Stowell et al., 2014; Wang et al., 2002) or intact LPS 
(Stowell et al., 2014; Thirumalapura, Morton, Ramachandran, & 
Malayer, 2005). The value of these microbial glycan-focused arrays has 
been demonstrated in examining host responses to pathogenic bacteria, 
such as Escherichia coli, Klebsiella pneumoniae, Salmonella enterica, Sal-
monella typhimurium and Shigella flexneri, among others (Geissner et al., 
2019; Stowell et al., 2014; Thirumalapura et al., 2005). However, to the 
best of our knowledge, none of these arrays have covered glycan frag-
ments or intact LPSs from H. pylori strains. 
The present work has aimed to explore the structural diversity of 
LPSs from five different H. pylori clinical isolates associated with gastric 
pathologies, in comparison with the reference H. pylori strain 26695. To 
achieve this, a microarray of H. pylori LPSs and other bacterial LPSs was 
constructed for their interrogation with carbohydrate sequence-specific 
proteins to complement the information derived from GC-MS and elec-
trospray (ESI) mass spectrometry (MS) and tandem mass spectrometry 
(ESI-MSn) on the different LPS structural domains. The microarray 
generated was also used as a tool for recognition of H. pylori LPSs by host 
immune receptors and for serum antibody profiling against these poly-
saccharides in H. pylori-infected cases. 
2. Material and methods 
An overview of the strategy used in this work is in supplementary 
scheme 1. 
2.1. H. pylori strains and culture conditions 
Five H. pylori clinical isolates (14255, 14382, CI-117, 2191 and CI-5), 
associated with gastric conditions (peptic ulcer, reflux esophagitis, 
dyspepsia and chronic gastritis), and the reference strain 26695 (ATCC 
700392), were used in this study. H. pylori cells were recovered from 
frozen stock cultures (Brucella Broth with 20 % glycerol), plated onto 
Columbia agar media supplemented with 5 % (v/v) horse blood (bio-
Mérieux) and incubated at 37 ◦C for 72 h on a microaerobic atmosphere 
generated by GasPak EZ Campy Container System Sachets (BD). Cells 
were sub-cultivated after 48 h incubation periods in the conditions 
described above. The biomass was harvested to sterile phosphate buffer 
saline for subsequent extraction of their LPS. Culture purity was assessed 
by cellular morphology (curved Gram-negative bacilli) after Gram 
staining and by positive biochemical reactions for oxidase, catalase and 
urease tests (Table S1), following established procedures (Zhang et al., 
2015). 
2.2. Human sera 
Serum samples were collected at Centro Hospitalar do Porto 
(Portugal) using standard procedures. All cases and controls underwent 
white light upper endoscopy and biopsies from antrum and corpus were 
obtained for histopathological study and H. pylori culture (Marcos-Pinto 
et al., 2012). A total of 24 sera were used in this study: 12 from in-
dividuals Hp+ with moderate/severe inflammation and 12 from in-
dividuals Hp- with absent/mild inflammation. Clinical features 
regarding the analyzed Hp + and Hp- cases are in Table S2. The age of 
the infected individuals varied from 32 to 62, with an average value of 
47 years, and included 7 males and 5 females. For Hp- controls, the age 
of individuals varied from 18 to 59 with an average value of 39 years and 
included 5 males and 7 females. The criteria for selection of Hp + and 
Hp- control sera were based on the histology and culture tests (positive 
or negative for H. pylori), levels of serum H. pylori IgG/IgA antibodies 
detected with the anti-H. pylori ELISA commercial kit (EUROIMMUN 
Medizinische Labordiagnostika AG), degree of inflammation and infil-
tration of polymorphonuclear cells (PMN infiltration), observation of 
atrophy or intestinal metaplasia (Table S2). 
2.3. Extraction and fractionation of H. pylori LPSs 
H. pylori LPSs were extracted from 1− 2 g of bacteria by the hot 
phenol-water method (Westphal & Jann, 1965). The LPS-enriched 
aqueous layer was recovered, dialyzed (membrane cut-off 1 kDa) and 
lyophilized. The resulting material (19− 58 mg dry weight) was resus-
pended in 50 mM Tris-HCl (pH 7.5) containing 6 mM MgCl2 and 2 mM 
CaCl2 and subject to enzymatic treatments with DNAse, followed by 
RNAse, each overnight at 37 ◦C, and by proteinase K, overnight at 45 ◦C, 
to remove nucleic acids and protein contaminants, respectively. DNAse 
(EN0521), RNAse (EN0531) and proteinase K (EO0491) were from 
Thermo Fisher Scientific. 
LPSs were fractionated by gel filtration on a Sephacryl S-300 HR (GE- 
Healthcare, 2− 400 kDa) column (0.77 m length and 1.6 cm diameter), 
previously calibrated with blue dextran 2 MDa, dextrans 150 kDa and 12 
kDa, and Glc (all from Sigma), and the average molecular weights (Mw) 
estimated (Fig. S1). The samples were eluted with 3 M urea in 0.1 M 
phosphate buffer (pH 6.5) at a flow rate of 0.5 mL/min, and 1 mL 
fractions were collected. Absorbance at 260 and 280 nm was used to 
monitor nucleic acids and protein contents, respectively. Total mono-
saccharide content was determined by the colorimetric phenol-sulfuric 
acid method (Dubois, Gilles, Hamilton, Rebers, & Smith, 1951) and 
L.M. Silva et al.                                                                                                                                                                                                                                 
Carbohydrate Polymers 253 (2021) 117350
3
expressed as equivalents of glucose. The fractions rich in carbohydrates, 
corresponding to LPS fractions, were dialyzed, lyophilized and stored in 
a desiccator at room temperature until further analysis. 
H. pylori LPSs (10–50 μg) from S-300 fractions were separated by 
SDS-PAGE as described (Laemmli, 1970) with some modifications. 
Briefly, the lyophilized H. pylori LPSs were dissolved in the Tris 
(hydroxymethyl)aminomethane (Tris)-based sample buffer (NP0008, 
Invitrogen) and heated for 10 min at 100 ◦C. H. pylori LPS samples 
(10–20 μL) and a LPS molecular marker (250 μg/mL, P-20495, Molec-
ular Probes) were run on a Bis-Tris mini precast 1 mm polyacrylamide 
gel of 4–12 % acrylamide gradient (Invitrogen) at 35 mA in the 
2-(N-morpholino)ethanesulfonic acid (MES) running buffer (Invitrogen) 
for 90 min. The gel was fixed with 50 % (v/v) ethanol and 10 % (v/v) 
acetic acid in ultrapure water, for 60 min, and visualized using a 
commercially available silver staining kit (PROTSIL1-1KT, Sigma) (Tsai 
& Frasch, 1982). 
2.4. H. pylori LPS-derived oligosaccharides 
Aiming to obtain representative oligosaccharide structures present in 
the clinical isolates that differ from the reference strain, LPSs from CI-5 
and 26695 were selected and subjected to partial acid hydrolysis with 50 
mM trifluoracetic acid (TFA) for 1 h at 65 ◦C. The TFA was evaporated at 
room temperature, and the resulting mixture was re-suspended in 
distilled water and fractionated by gel filtration on a polyacrylamide 
Bio-Gel P2 (Bio-Rad, 1.0 m length and 1.0 cm diameter), at a constant 
flow of 0.5 mL/min. Fractions of 1 mL were collected and assayed for 
total sugars using the phenol-sulfuric acid method as above. 
2.5. Glycosidic linkage analysis 
The composition of H. pylori LPSs and LPS-derived oligosaccharides 
(80 μg total sugars) was determined by methylation analysis following 
the NaOH/Me2SO/CH3I method (Ciucanu & Kerek, 1984). The meth-
ylated polysaccharides were hydrolyzed with 2 M TFA at 121 ◦C for 60 
min, reduced with NaBD4, and acetylated with acetic anhydride in the 
presence of 1-methylimidazole (Coimbra, Delgadillo, Waldron, & Sel-
vendran, 1996; Harris, Henry, Blakeney, & Stone, 1984). The partially 
methylated alditol acetates were dissolved in anhydrous acetone and 
analyzed by GC-MS (Agilent Technologies 6890 N Network Gas Chro-
matography connected to an Agilent 5973 Selected Mass Detector). The 
GC was equipped with a DB-1 ms capillary column (100 % dime-
thylpolysiloxane, 30 m length, 0.25 mm internal diameter, and 0.10 μm 
film thickness) (122− 0131, Agilent). The samples were injected in 
splitless mode (time of splitless 1.00 min), with the injector and detector 
operating at 230 ◦C, using the following temperature program: 50 ◦C (9 
min) → 140 ◦C (5 min) at 10 ◦C/minute → 170 ◦C (1 min) at 0.5 ◦C/min 
→ 230 ◦C (2 min) at 60 ◦C/min. 
2.6. Mass spectrometry 
The LPS-derived oligosaccharides were analyzed using a linear ion- 
trap (LIT) mass spectrometer (LIT LXQ, Thermo Finnigan, San Jose, 
CA, USA) with electrospray (ESI) ionization and the conditions were as 
follows: electrospray voltage 5 kV; capillary temperature 275 ◦C; 
capillary voltage 1 V; and tube lens voltage 40 V; 100 μL of diluted 
sample; flow rate 8 μL/min. Nitrogen was used as nebulizing and drying 
gas. In tandem MS (MSn) experiments, the collision energy used was set 
between 18 and 31 (arbitrary units). Data acquisitions were carried out 
on an Xcalibur data system. Prior to ESI-MS and MSn analysis, dried 
oligosaccharides were dissolved in milli-Q water and de-salted on a 
Dowex cation-exchange resin (20− 50 mesh, Bio-Rad, Hercules, CA, 
USA). The supernatants were recovered and 10 μL of each sample were 
diluted in water/methanol (1:1, v/v) containing 0.1 % formic acid. ESI- 
MS and ESI-MSn spectra were acquired in the positive mode, scanning 
the mass range from m/z 100 to 1500 in ESI-MS experiments. 
2.7. Carbohydrate microarray construction and analysis 
To construct the carbohydrate microarray, here designated ‘H. pylori 
LPS microarray’, the six structurally analyzed LPSs from H. pylori clin-
ical isolates and 26695 strain were immobilized non-covalently onto 16- 
pad nitrocellulose coated glass slides, together with thirty-seven car-
bohydrate probes (Table S3). These included seven LPSs from other 
Gram-negative bacteria, twenty-three sequence-defined lipid-linked ol-
igosaccharides, prepared as neoglycolipids (NGLs), and seven poly-
saccharides. Detailed information on the carbohydrate probes, 
microarray construction, printing conditions, imaging and data analysis, 
compliant with the Minimum Information Required for A Glycomics 
Experiment (MIRAGE) guidelines for reporting glycan microarray-based 
data (Liu et al., 2016), is available in Table S4. 
Twenty-four carbohydrate-binding proteins, including plant and 
Fig. 1. General architecture of H. pylori LPS 
based on (Li et al., 2017) and adapted from 
(Ferreira et al., 2012). a) Previously proposed 
LPS domains structure of H. pylori 26695 with 
the O-antigen containing Lewis (Le)y/x de-
terminants and N-acetyllactosamine (LacNAc) 
backbones, and the inner and outer core 
comprising the conserved hexasaccharide, and 
the Trio, glucan and heptan, respectively; b) 
redefinition of the LPS domains with the 
O-chain encompassing the epitopes previously 
assigned to the outer core OS (Trio, glucan and 
heptan) and the well-established LacNAc and Le 
determinants; c) The LPS of H. pylori SS1 strain 
containing ribans (Altman et al., 2011b). The 
representation of glycans follows the guidelines 
of Symbol Nomenclature for Glycans (Neela-
megham et al., 2019). Abbreviations: Fuc, 
fucose; Gal, galactose; Glc, glucose; GlcN, 
glucosamine; GlcNAc, N-acetylglucosamine; 
DD-Hep, D-glycero-D-manno-heptose; LD-Hep, 
L-glycero-D-manno-heptose; Kdo, 3-deoxy--
D-manno-octulosonic acid; PEtN, phosphoetha-
nolamine; Ribf, ribofuranose.   
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human immune lectins, and monoclonal antibodies (mAbs), were 
analyzed in the H. pylori LPS microarray. Information on their names, 
sources, conditions of analysis and their reported carbohydrate recog-
nition is detailed in Table S5. The microarray binding analyses were 
performed as described (Liu et al., 2012). The plant lectins and the 
anti-glucan 16.412E-IgA and 3.4.1G6-IgG3 antibodies were all bio-
tinylated, thus a single-step overlay protocol was carried out. Briefly, for 
these, the microarray slides were blocked for 60 min with 1 % or 3 % 
(w/v) bovine serum albumin (BSA, Sigma) in 10 mM HEPES-Buffered 
Saline (pH 7.3), 150 mM NaCl, 5 mM CaCl2 (referred to as HBS) with 
or without casein (Pierce), followed by the overlay, for 90 min, with the 
different proteins diluted in the blocking solutions to the final concen-
trations given in Table S5. 
The human lectins and the antibodies were analyzed using biotin- 
streptavidin detection system. In brief, after the blocking step, the 
microarrays were overlaid for 90 min with the antibody solutions pre-
pared to the final concentrations/dilutions given in Table S5, followed 
by incubation with the corresponding detection reagents in specified 
blocking solutions for 60 min. The human galectin-3 was analyzed at 50 
μg/mL in 1 % (w/v) BSA, 0.02 % (v/v) casein in HBS, 5 mM, with 
detection using mouse monoclonal anti-poly-Histidine (Ab1), for 60 
min, followed by biotinylated anti-mouse IgG (Ab2) for 60 min, both at 
10 μg/mL in the blocking solution (Table S5). 
For analysis of the 24 human sera from Hp + and Hp- individuals, the 
slides were blocked with 3 % (w/v) BSA in 1 % casein (blocking solu-
tion) for 60 min, followed by the overlay with the sera diluted 1:100 in 
the blocking solution for 90 min. In preliminary analyses, the serum 
from one Hp+ and one Hp- individuals was analyzed for IgM and IgG 
antibodies detected using biotinylated anti-human IgM or anti-human 
IgG (1:200 in the blocking solution), respectively. As binding was 
distinct with detection of IgG, but not of IgM antibodies (Fig. S2), only 
the IgG antibody profiles against H. pylori and other bacterial LPSs of 
both infected and non-infected control groups were evaluated. 
The detection reagents in the absence of the proteins or human sera 
were also analyzed to detect any nonspecific binding. For all the 
microarray analyses, the Alexa Fluor-647-labeled streptavidin (1 μg/mL, 
Molecular Probes, S21374), diluted in the corresponding blocking so-
lutions (Table S5), was used for readout, using a GenePix® 4300A 
fluorescence scanner (Molecular Devices, UK). The parameters for 
recording the fluorescence images were selected considering the signal 
to noise ratio, and saturation of the spot signals in the different exper-
iments (Table S4). The analyses were performed at ambient tempera-
ture, except for anti-i P1A ELL antibody that was at 4 ◦C. Microarray 
data analysis was performed using dedicated software developed by 
Mark Stoll of the Glycosciences Laboratory, as described (Stoll & Feizi, 
2009). 
2.8. Ethics statement 
The H. pylori clinical isolates were recovered from gastric biopsies of 
patients with gastric symptoms being investigated at Hospital de Santo 
António (Porto, Portugal). All procedures were approved by the Ethical 
committees of Centro Hospitalar do Porto (Portugal) and written 
informed consent was received from all participants. 
3. Results and discussion 
3.1. Fractionation and structural analysis of H. pylori LPSs 
The LPSs of the five H. pylori clinical isolates and from the 26695 
were recovered from the aqueous phase after hot phenol-water extrac-
tions and fractionated on a Sephacryl S-300. Based on the chromato-
graphic profiles (Fig. S3), the average Mw of each LPS was calculated 
and estimated as 300 kDa for 26695, 340 kDa for CI-117 and 14255, 290 
kDa for 14382 and 20 kDa for 2191 and CI-5, pointing to different LPS 
structural features in the strains. This interstrain variability was 
visualized by SDS-PAGE analysis and silver staining (Fig. S4). Greater 
microheterogeneity and similar banding profile was observed with the 
LPS from strains 26695, CI-117, 14255, and 14382, when compared 
with those from 2191 and CI-5 strains. Irrespective of this variability, the 
LPSs studied showed the ladderlike arrangement characteristic of 
smooth-LPS (Amano, Yokota, & Monteiro, 2012; Hiratsuka et al., 2005; 
Mills, Kurjanczyk, & Penner, 1992; Monteiro et al., 2000). The differ-
ential migration of major bands in the mid region of the gel, is consistent 
with different O-antigen chain lengths of the LPS (Fig. S4). 
Methylation analysis of the different Sephacryl S-300 LPS fractions 
showed a complex mixture of partially methylated alditol acetates 
(Table 1, columns a, and Fig. S5). These were grouped and assigned to 
the different regions of the LPS (Fig. 1) (Li et al., 2017). All H. pylori LPS 
contained fucose (Fuc), glucose (Glc), galactose (Gal), N-acetylglucos-
amine (GlcNAc) and heptose (Hep) residues but with distinct relative 
molar ratios of glycosidic linkages. Terminal Fuc (t-Fuc, 2 %–16 %), 
3-linked Gal (8 %–41 %), 4-linked (2 %–36 %) and 3,4-linked GlcNAc (2 
%–10 %), characteristic of the O-chain region of a smooth-LPS, were 
present in all strains as major structural units (Table 1, columns a, and 
Fig. S5). These findings point to the occurrence of type 2 (poly)LacNAc 
moieties, (-3Galβ1-4GlcNAcβ1-)n, also known as i-antigen (Feizi, 1981), 
and type 2 Lex antigen, -3Galβ1-4(Fucα1-3)GlcNAcβ1-, or to its type 1 
chain Lea isoform, -3 Galβ1-3(Fucα1-4)GlcNAcβ1- (Kabat, 1982; Wat-
kins, 1980). The 2-linked Gal, indicative of a type 2 Ley sequence, 
Fucα1-2Galβ1-4(Fucα1-3)GlcNAcβ1-, or its type 1 Leb isomer, 
Fucα1-2Galβ1-3(Fucα1-4)GlcNAcβ1- (Kabat, 1982; Watkins, 1980), was 
not detected by –GC-MS analysis. The unexpected absence of Ley, 
particularly in strain 26695, was likely due to the very limited amounts 
of the starting material used for methylation analysis and/or to the high 
microheterogeneity of the studied LPS. In addition to Le determinants 
and LacNAc moieties, the occurrence of 4,6-linked GlcNAc residues in 
the LPS from 14255 strain (Table 1, column a) points to a partial glu-
cosylation and/or galactosylation at the O-6 position of GlcNAc residues 
of the (poly)LacNAc backbone in replacement of some α-L-Fuc 
side-chains at O-3, similarly to what was observed for strains UA861 
(Monteiro, Rasko, Taylor, & Perry, 1998) and 471 (Aspinall, Mainkar, & 
Moran, 1999). 
A distinctive feature of 14382 LPS was the high abundance of 3- 
linked Gal residues. Out of 41 %, only 6 % seems to link 1,4-GlcNAc 
residues to form type 2 LacNAc backbone in a relative molar propor-
tion of 1:1 (Table 1, column a). The remaining 35 % of 3-linked Gal units 
point to the occurrence of a 1,3-D-galactan. This structure was so far 
identified in the LPS from a mutant of the H. pylori strain SS1, the SS1 
HP0826::Kan (Chandan, Jeremy, Dixon, Altman, & Crabtree, 2013). 
Considering the recent redefinition of H. pylori LPS domains, these gal-
actans are assigned to the O-antigen variable region of LPS (Li et al., 
2017). 
The presence of 6-linked Glc residues in LPS from strains 26695 and 
2191 (Table 1, column a), points to the existence of an α1,6-glucan, 
resembling dextran polymers previously observed (Altman, Chandan, Li, 
& Vinogradov, 2011; Monteiro, 2001). This homopolymer has been 
postulated to cap, through a nonreducing DD-Hep residue, the Trio 
moiety DD-Hep-Fuc-GlcNAc, which in turn is attached to the 2,7-linked 
Hep of the short core OS of the LPS (Glc-Gal-D-
D-Hep-LD-Hep-LD-Hep-Kdo) (Fig. 1) (Li et al., 2017). Also, the detection of 
3-DD-linked Hep residues in these strains points to a heptoglycan linked 
to the nonreducing extended α1,6-glucan chain in the O-antigen 
(Table 1). This structural linearity of heptan-glucan-Trio region has been 
reported to the recently reinvestigated LPS structures from the western 
strains 26695 (Altman et al., 2011a; Li et al., 2017), SS1 (Altman et al., 
2011b) and O:3 (Altman, Chandan, Li, & Vinogradov, 2013), as depicted 
in Fig. 1. 
Notably, 2-linked ribofuranosyl units, 2-Ribf, were identified in the 
LPSs of all clinical isolates, except 2191, with only trace amount 
(Table 1, column a), suggesting the occurrence of β1,2-D-ribans (with 
3–5 Ribf units), a homopolymer found in SS1 strain (Altman et al., 
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2011b; Chandan et al., 2013). This homopolymer is now assigned to the 
O-antigen domain of the LPS (Fig. 1) (Li et al., 2017). Consistent with 
previous findings (Altman et al., 2011a; Li et al., 2017; Monteiro et al., 
2000), there is no evidence of ribans on the LPS of 26695. 
3.2. Mass spectrometry analysis of H. pylori LPS-derived oligosaccharides 
Aiming to obtain oligosaccharide structures that could corroborate 
and further elucidate the proposed sequences above and be represen-
tative of those existing in the clinical isolates, such as ribans, the LPSs 
from strains 26695 and CI-5 were subjected to partial acid hydrolysis 
under mild conditions. Due to the acid-lability of certain sugar residues 
(e.g. Fuc), methylation analysis showed some differences in the relative 
molar ratio in LPS-derived high Mw fraction, remaining after hydrolysis 
(#A, Fig. 2) when comparing with that observed to the non-hydrolyzed 
LPS (Table 1, column b). However, the glycosidic linkages previously 
identified were the same after the partial acid hydrolysis treatment. 
Considering the known heterogeneity and complexity of the LPS 
structures and the lower ionization efficiency high MW oligosaccha-
rides, the low Mw oligosaccharide fractions (#B-#E, Fig. 2) were 
analyzed by ESI-MSn. The oligosaccharides identified in the different 
LPS-oligosaccharide fractions were detected as protonated ions or so-
dium adducts (Table 2 and Fig. 3). 
The proposed glycan sequences assigned below were based on GC- 
MS and ESI-MSn analyses and on previously knowledge on H. pylori 
LPS structures (2011b, Altman et al., 2011a; Ferreira, Domingues, Reis, 
Monteiro, & Coimbra, 2010; Li et al., 2017). The ion at mass-to-charge 
ratio (m/z) 1063, identified in both 26695 and CI-5 oligosaccharide 
fractions, was assigned to a double repeating unit of Lex determinants, 
[Lex-Lex + Na]+, as part of the O-antigen of the LPS (Fig. 3a). The 
Table 1 
Glycosidic linkage profile (relative molar ratio, %) of Sephacryl S-300 and Bio-Gel P2 fractions of the studied H. pylori LPS.  
LPS domain Linkage type 
Relative molar ratio (%)* 
14255 14382 CI-117 2191 CI-5 26695 
(a) (a) (a) (a) (a) (b) (a) (b)  
Lewis antigens & (poly)LacNAc          
t-Fuc 8.4 7.5 4.5 2.4 15.9 9.0 7.6 4.3  
t-Gal 2.4 1.6 0.6 1.9 6.7 3.9 1.2 1.9  
2-Gal - - - - - - - -  
3-Gal 16.3 41.0 18.9 13.8 25.2 15.0 8.0 10.2  
2,3-Gal 0.4 0.6 0.5 0.3 0.2 0.5 0.4 0.7  
3,6-Gal 0.2 - - - 0.3 0.3 - -  
2-Glc - - - - - - 0.2 -  
t-GlcNAc 0.1 0.2 0.3 0.5 - 0.6 2.1 3.9 
O-antigen 4-GlcNAc 9.5 6.1 29.9 35.8 7.9 17.6 2.0 9.4  
3,4-GlcNAc 9.9 3.1 5.5 2.1 10.2 22.8 10.4 11.4  
4,6-GlcNAc 8.8 - 0.6 0.4 - 0.3 - -  
3,4,6-GlcNAc 1.9 - - - - - - -  
Riban          
t-Ribf 0.3 0.7 0.4 - 0.6 0.2 - -  
2-Ribf 8.5 13.4 9.7 tr 15.9 10.8 - -  
Glucan          
6-Glc 0.4 0.4 0.6 16.1 0.2 - 6.4 9.3  
Amylose-like glycan          
4-Glc 1.3 0.5 0.5 2.4 0.5 0.6 1.0 1.0  
Mannose-rich glycans          
t-Man 0.2 - - - 0.1 - - -  
Heptan          
3-dd-Hep - - - 3.8 - - 0.8 1.3  
Trio          
6-dd-Hep - - 0.8 5.7 - - 1.8 1.4  
3-Fuc 1.0 1.8 1.1 0.6 1.5 1.1 0.4 0.7  
3-GlcNAc 1.5 0.7 2.6 3.4 0.6 1.5 - -  
3-Glc 1.3 2.4 1.7 1.3 1.8 1.4 0.6 0.8  
2-dd-Hep 1.6 2.4 1.2 0.7 1.5 1.0 1.6 1.7  
t-Glc 8.4 2.4 3.1 2.3 0.6 0.3 9.4 7.7  
4-Gal 1.1 2.5 2.1 0.7 1.2 0.7 2.6 2.5  
7-dd-Hep 3.9 4.9 4.8 0.3 3.3 3.2 6.5 5.7 
Core 2,7-dd-Hep 5.4 3.2 - - 4.1 6.9 6.0 11.0  
2-ld-Hep 1.1 1.8 1.2 1.4 1.2 0.7 2.4 3.4  
3-ld-Hep - - - 0.3 - - - -  
t-dd-Hep - 0.3 0.3 1.3 - - 0.9 1.0 
Lipid A 6-GlcNAc 4.9 1.4 8.1 - - - 25.5 8.0  
4-Xyl 0.2 - 0.1 0.7 - - 0.6 - 
Not 3,4-Glc 0.7 0.7 0.7 0.4 0.4 0.5 0.9 - 
assigned 4,6-Glc - - - 0.7 - - - - 
sugars 3,6-Glc - - - 0.4 - - - -  
2-Ribp 0.1 0.3 - - 0.2 0.4 - -  
* The relative molar ratio of each linkage type was calculated by dividing the area of the corresponding chromatogram peak by the sugar residue molecular weight. 
(a), LPS fractions of Sephacryl S-300 after treatment with nucleases and proteinase K; (b), LPS fractions of Bio-Gel P2 after hydrolysis with 50 mM TFA, 65 ◦C, 1 h. The 
LPS domains were arranged according to the recently published redefinition of these (Li et al., 2017). Abbreviations: Fuc, fucose; Gal, galactose; Glc, glucose; GlcNAc, 
N-acetylglucosamine; DD-Hep, D-glycero-D-manno-heptose; LD-Hep, L-glycero-D-manno-heptose; Man, mannose; Rib, ribose; Xyl, xylose; tr, traces; ‘- ‘not detected. The 
series of the sugars was considered the same as that occurring in nature: Fuc, L-series; hexoses, Rib and Xyl, D-series. For heptoses (DD- and LD-Hep) the assignment was 
based on published structures (Monteiro, 2001) and on GC–MS analyses. All hexoses showed to be present in pyranose form, and Rib occurred mainly in the furanose 
form. 
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occurrence of Lex, instead of Lea determinants was supported by the 
presence of the fragment ion at m/z 388 (Fig. 3a), which was previously 
reported as a diagnostic fragment ion for type 2 Lex structures found in 
the strain NCTC 11637. Under similar MS analysis conditions, the type 1 
Lea isomer had a diagnostic ion at m/z 372 (Ferreira, Domingues et al., 
2010), not detected here. The molecular ions and corresponding 
assigned structures [GlcNAc-Rib4 + Na]+ (m/z 772), [Rib3-Gal-Gl-
c-Hep-Fuc + Na]+ (m/z 1099) and [Rib2-Gal-Glc-Hep-Fuc + Na]+ (m/z 
967) were identified only in CI-5 fractions (Table 2 and Fig. 3b,c). The 
detection of these fragment ions corroborated the presence of a riban 
structural domain in the CI-5 LPS, that is likely to bridge the variable 
region of the O-chain encompassing (poly)LacNAc and/or Le de-
terminants and the conserved Trio (DD-Hep-Fuc-GlcNAc) through the 
Gal-Glc residues, as depicted in Fig. 1. 
Collectively, the structural analysis of the different LPSs provided 
insights into their monosaccharide composition, glycosidic linkage 
patterns and contributed to the assignment of their sequences in the core 
and O-chain LPS domains. LPS structural differences were observed 
between clinical isolates and 26695, such as the occurrence of ribans in 
the former, but not in the latter; as well as within the clinical isolates, 
such as the evidence of a galactan domain in the LPS from 14382 and CI- 
117 strains, reinforcing the structural complexity and heterogeneity of 
these polysaccharides. 
3.3. Construction of H. pylori LPS microarray and analysis with 
sequence-specific proteins 
To explore the recognition of H. pylori LPSs by proteins, a carbohy-
drate microarray was constructed, featuring the 6 analyzed LPSs and a 
selection of oligosaccharides with defined sequences, such as poly-
lactosamine Ii-active, Le and blood group H-related, which are known to 
occur on the H. pylori O-chains. As controls, the microarray included 
LPSs from other Gram-negative bacteria, Glc- and GlcNAc-based homo- 
oligomers, and Glc- and Man-containing polysaccharides, which are 
structures that have been reported in H. pylori LPS and other pathogens 
(Table S3). 
The microarray was first analyzed with a total of 22 carbohydrate 
sequence-specific proteins (Table S5). These included monoclonal an-
tibodies (mAbs) directed at Le and blood group H-related sequences (the 
anti-Lex mAbs anti-BG7, anti-SSEA1 and anti-L5, anti-Ley, anti-SLex, 
anti-Lea, anti-Leb, anti-LNT, anti-H-type 1 and anti-H-type 2), linear 
polyLacNAc sequences (anti-i P1A ELL1), and α1,6-glucose sequences 
(anti-dextran 16.412E-IgA and 3.4.1G6-IgG3). Also analyzed were plant 
lectins with various specificities: Aleuria aurantia lectin (AAL) and Ulex 
europaeus agglutinin-I (UEA-I) towards fucosylated sequences; Ricinus 
communis-I (RCA120), Datura stramonium lectin (DSL), Lycopersicon 
esculentum lectin (LEL), Wheat germ agglutinin (WGA), Solanum tuber-
osum lectin (STL) and Griffonia Simplicifolia lectin-II (GSL-II) towards 
LacNAc or β1,4-linked N-acetyllactosamine (GlcNAc) oligosaccharide 
sequences; and Concanavalin A (ConA) towards α-mannose. Distinct 
binding profiles were observed to the sequence-defined carbohydrate 
probes with a good correlation with reported specificities of the probes, 
which served as validation and quality control of the analysis (see Ap-
pendix B for the analysis with the full microarray set). The binding 
patterns of these proteins with the H. pylori LPSs are highlighted in 
Fig. 4. 
3.3.1. Fucosylated blood group-related sequences 
The binding of AAL to all the H. pylori LPS was indicative of the 
presence of α-fucose. But the differential recognition obtained with the 
anti-Le mAbs, UEA-I and the anti-blood groups H-type 1- and H-type 2 
mAbs (Fig. 4 and Appendix B), pointed to distinct fucosylated sequences 
in the H. pylori LPS. 
The anti-Lex mAbs, anti-SSEA1 (Gooi et al., 1981), anti-L5 (Streit 
et al., 1996) and anti-BG7, which exhibited specific binding to the probe 
with the Lex sequence (LNFPIII, #16 Appendix B), showed good binding 
to the LPSs from 14255, 2191 and 26695, in addition to weak, but 
detectable binding to the LPS from CI-5 (Fig. 4 and Appendix B). These 
indicated the presence of Lex-related antigens in these LPSs, but not in 
those from 14382 and CI-117 clinical isolates, corroborating the pro-
posed glycan sequences in the structural analysis. Although methylation 
analysis was elusive, detection of binding with anti-Ley was readily 
demonstrated to all H. pylori LPSs, pointing to the occurrence of these 
antigens. Binding to LPSs was not detected with anti-Lea nor anti-Leb 
mAbs, suggesting the absence of type 1 Lea/b antigens, and that the Le 
Fig. 2. Chromatographic profiles of H. pylori LPSs from 26695 and CI-5 strains obtained by gel filtration on Bio-Gel P2 after partial acid hydrolysis with 50 mM TFA 
for 1 h at 65 ◦C. Absorbance was measured at 490 nm to assess the content of total sugars. #A is the high Mw fraction analysed to their glycosidic linkages by GC–MS 
(Table 1); #B-#E are low Mw fractions analysed by ESI-MSn (Table 2 and Fig. 3). 
Table 2 
Identified ions in the ESI-LIT-MS spectra of low Mw glycan-rich fractions of Bio- 
Gel P2 from H. pylori 26695 and CI-5 (50 mM, 65 ◦C, 1 h), and the proposed 




552 [Lex + Na]+ (#E)  
653 [Hex4 − 2H2O + Na]+ (#E)  
772  [GlcNAc-Rib4 + Na]+ (#C) 
789 [Hex2-Hep-Hep(P) − H2O + H]+
(#C)  
802  [LacNAc-Rib3 + Na]+ (#C) 
917 [Lex-LacNAc + Na]+ (#B, #D)  
933 [LacNAc-Hex-LacNAc + Na]+ (#C)  
967  [Rib2-Gal-Glc-Hep-Fuc + Na]+
(#C) 
1063 [Lex-Lex + Na]+ (#B, #D and #E) [Lex-Lex + Na]+ (#B) 
1099  [Rib3-Gal-Glc-Hep-Fuc + Na]+
(#C) 
1231  [Rib4-Gal-Glc-Hep-Fuc + Na]+
(#B) 
The proposed glycan sequences were based on the ESI-MSn analyses (Fig. 3) and 
on previously published H. pylori LPS structures (Altman et al., 2011b; Ferreira, 
Domingues et al., 2010; Li et al., 2017; Monteiro, 2001). The fractions (in 
brackets) are depicted in Fig. 2. Abbreviations: Fuc, fucose; Gal, galactose; Glc, 
glucose; GlcNAc, N-acetylglucosamine; Hep, heptose; Hex, hexose; LacNAc, 
N-acetyllactosamine; Lex, Lewisx antigen, Gal-(Fuc)-GlcNAc; Rib, ribose; P, 
phosphate. 
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backbone-type structures are of type 2. In fact, the expression of Lex/y 
and the absence of Lea/b antigens were reported for strains 26695 (Li 
et al., 2017), 11637 (Aspinall, Monteiro, Pang, Walsh, & Moran, 1996), 
SS1 (Altman et al., 2011b) and J99 (Monteiro et al., 2000). The results 
are in accordance with the screening analyses using anti-Le antibodies, 
which have shown that type 2 Lex/y are the dominant phenotypes in 
western hosts, contrasting to Asian population that carry predominantly 
type 1 Lea/b antigens (Monteiro, 2001). 
The UEA-I and anti-H-type 2 mAb, both of which recognize H-type 2 
(Fucα1-2Galβ1-4GlcNAc-) sequence as in LNnFP-I (#14, Appendix B, 
and Table S5), showed strong binding to the LPSs from CI-117 and 
14382 clinical isolates (Fig. 4 and Appendix B). These LPSs were also 
strongly bound by the anti-H-type 1 mAb, which recognizes Fucα1- 
2Galβ1-3GlcNAc- sequence as in LNFP-I (#13, Appendix B, and 
Table S5). Binding could also be detected with H-type 2 and H-type-1 
mAbs to CI-5 and 2191 LPS. The binding with anti-H-type 2 antibody 
could also be due to the expression of Ley determinants in these LPS, as 
this antibody bound, albeit weakly, to Ley probe (LNnDFH-I, #20, Ap-
pendix B), probably due to the shared Fucα1-2Galβ1-4- epitope. The 
microarray binding data obtained with these antibodies showed the 
occurrence of H-type 1 and H-type 2 determinants in H. pylori LPS. 
Intriguingly the latter, to our knowledge, has not been described to date. 
The expression of H-type 2 sequences may be a result of the incomplete 
biosynthesis of Ley epitopes identified in these LPSs. Noteworthy was the 
negligible or no binding of these blood-group H specific proteins to the 
LPSs from 14255 and 26695 which gave the strongest binding with anti- 
Lex antibodies (Fig. 4 and Appendix B). None of the studied LPSs were 
bound by anti-sialyl Lex mAb nor by anti-LNT mAb (Fig. 4 and Appendix 
B), pointing to the absence of sialylated Lex and non-fucosylated type-1 
structures (Galβ1-3GlcNAc), respectively. 
The diverse fucosylation profile within H. pylori cell surface is 
regarded as a form of molecular mimicry to evade/modulate the host 
immune response, contributing to the pathogenesis and virulence of the 
bacterium (Moran, 2008). 
3.3.2. GlcNAc, LacNAc and polyLacNAc sequences 
The linear type 2 polyLacNAc sequences of LPSs were detected using 
the anti-i P1A ELL mAb (Fig. 4, Appendix B and Table S5). This mAb had 
a distinctive binding profile with CI-117 and 14382 LPS (Fig. 4 and 
Appendix B). The anti-i P1A ELL mAb recognizes substituted linear 
polyLacNAc sequences, whereas the lectins DSL, LEL, WGA and STL, 
which recognize terminal or internal (poly)LacNAc (Table S5), bound 
not only to the CI-117 and 14382 LPSs, but also to 14255 LPS, followed 
by those from strains 2191 and CI-5 (Fig. 4 and Appendix B), supporting 
the proposed structures inferred by the structural analysis. The weak 
interaction with 2191 and CI-5 LPSs was probably related to their low 
average Mw and the less efficient retention on nitrocellulose after the 
different incubations and several washes during microarray analyses. 
The nonreducing terminal β-galactose in the LPS was detected with 
RCA120 lectin (Table S5), which showed strong binding to 14382 LPS 
(Fig. 4 and Appendix B), likely related with the expression of a 3-galac-
tan in this LPS, as suggested by methylation analysis. Negligible or no 
binding was detected to any of H. pylori LPS with GSL-II that has spec-
ificity for terminal α-or β4-linked GlcNAc residues. 
3.3.3. α-Glucose and α-mannose-related sequences 
The 16.412E-IgA and 3.4.1G6-IgG3A antibodies bound to α1,6- 
glucan sequences (#29 and #40, Appendix B), as expected, but did not 
recognize the LPSs studied here (Table 1 and Appendix B). The lack of 
binding with anti-16.412E-IgA, known to be specific for nonreducing 
terminal α1,6-linked glucan sequences, was predicted to the H. pylori 
LPSs, as the α1,6-glucan reported (Altman et al., 2011a; Monteiro, 2001) 
Fig. 3. Positive-ion mode ESI-LIT-MSn spectra of representative H. pylori oligosaccharide fractions of Bio-Gel P2 (Fig. 2 and Table 2). The proposed assignement of 
the glycan moities were based on the ESI-MSn analyses and on previously published H. pylori LPS structures (Altman et al., 2011b; Ferreira, Domingues et al., 2010; Li 
et al., 2017; Monteiro, 2001): a) di-Lewisx antigen, b) -GlcNAc-Rib4-, c) -Rib2-Gal-Glc-Hep-Fuc-. a1) ESI-MS2 spectrum of the ion at m/z 1063.5, assigned to [Lex-Lex 
+ Na]+; a2) ESI-MS3 spectrum of the product ion at m/z 917.5, assigned to [Lex-LacNAc + Na]+, derived from the ion at m/z 1063.5; a3) ESI-MS4 spectrum of the 
product ion at m/z 771.4, assigned to [LacNAc-LacNAc + Na]+, from the product ion at m/z 917.5, derived from the ion at m/z 1063.5; a4) ESI-MS5 spectrum of the 
product ion at m/z 388.3, assigned to [LacNAc− H2O + Na]+, from the product ion at m/z 771.4, derived from the product ion at m/z 917.5, originated from the ion at 
m/z 1063.5; b1) ESI-MS2 spectrum of the ion at m/z 772.2, assigned to [GlcNAc-Rib4 + Na]+; (b2) ESI-MS3 spectrum of the product ion at m/z 569.3, derived from 
the ion at m/z 772.2; c1) ESI-MS2 spectrum of the ion at m/z 967.2, assigned to the structure [Rib2-Gal-Glc-Hep-Fuc + Na]+; (c2) ESI-MS3 spectrum of the product 
ion at m/z 703.4, from the ion at m/z 967.2; (c3) ESI-MS4 spectrum of the product ion at m/z 541.3 from the product ion at m/z 703.4 derived from the ion at m/z 
967.2. Product ion nomenclature follows that proposed by Domon and Costello (Domon & Costello, 1988). The most common fragmentation pathways, Y- and B-type 
glycosidic cleavages and A-type cross-ring cleavages (da Costa et al., 2012) are shown. The representation of glycans follows the guidelines of Symbol Nomenclature 
for Glycans (Neelamegham et al., 2019). Abbreviations: Fuc, fucose; Gal, galactose; Glc, glucose; GlcNAc, N-acetylglucosamine; DD-Hep, D-glycero-D-manno-heptose; 
Ribf, ribofuranose. 
Fig. 4. Carbohydrate microarray analyses of 
the binding of glycan sequence-specific mono-
clonal antibodies, plant lectins and human im-
mune lectins to LPS from H. pylori strains 
14255, 14382, CI-117, 2191, CI-5 and 26695. 
The proteins are named on the left; apart from 
the two human immune lectins, dendritic cell- 
specific ICAM-3-grabbing non-integrin (DC- 
SIGN) and galectin-3, the proteins are grouped 
according to their glycan recognition summa-
rized on the right: fucosylated blood group- 
related sequences; GlcNAc, LacNAc and poly-
LacNAc; and α-glucose and α-mannose se-
quences. The scales for the relative glycan 
binding intensities (fluorescence) are depicted 
at the bottom for each LPS; these are means of 
fluorescence intensities of duplicate spots of the 
high level of LPS arrayed (150 pg/spot). The 
error bars represent half of the difference be-
tween the two values. The full microarray set 
composed of 43 probes, and the binding data 
with all analyzed proteins is in Appendix B.   
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is internal, but the analysis with this antibody was included for quality 
control of the microarray. The anti-3.4.1G6-IgG3A preferentially binds 
internal α1,6-glucans with a chain length requirement of five or more 
residues (Palma et al., 2015). Although the expression of α1,6-glucan 
sequences in 26695 and 2191 LPSs was indicated by methylation anal-
ysis for 26695 and 2191 LPSs (Table 1), the negative array data with 
anti-3.4.1G6-IgG3A may be the result of a non-optimal presentation 
mode of these glycans in LPS for recognition by this antibody. ConA, 
which has a preference for terminal αMan-sequences as in probes 
#37-#39 (Appendix B), interacted very weakly with 14255 LPS only 
(Fig. 4). 
Together, the microarray results with sequence-specific proteins 
provided additional and complementary information on H. pylori LPS 
structural domains. In addition to corroborating the occurrence of Lex 
and (poly)LacNAc determinants in H. pylori LPS, microarrays revealed 
the expression of Ley, as well as H-type 1 antigens and evidenced, for the 
first time, the presence of H-type 2 determinants mainly in LPSs from 
14382 and CI-117 strains. 
3.4. Recognition of H. pylori LPS by host innate immune receptors 
To investigate the recognition of the studied LPSs by host proteins of 
the immune system, the H. pylori LPS microarray was interrogated with 
two human lectins: DC-SIGN and galectin-3. Among several biological 
functions, these lectins act as pattern recognition receptors of the im-
mune system for pathogen-associated molecular patterns from bacteria, 
fungi and parasites with ability to trigger immune responses (van Kooyk 
& Geijtenbeek, 2003; Vasta, 2012). 
The interaction between H. pylori and DC-SIGN has been suggested to 
be mediated by fucose-containing Lewis determinants on the O-antigen 
of LPS (Appelmelk et al., 2003). Consistent with its reported specificity 
(Geissner et al., 2019), the probes with Lea (LNFP-II, #15), Leb 
(LNDFH-I, #19), Lex (LNFP-III, #16), and Ley (LNnDFH-I, #20) se-
quences were strongly bound by DC-SIGN (Appendix B). Binding to 
H-type 2 (LNnFP-I, #14) and other Lewis-related oligosaccharides (#17 
and #18) was also observed, in addition to α-Man- and α-Glc- containing 
sequences (#37-#39 and #24-#26, #41, respectively) and chitooligo-
saccharides (#22 and #23). All H. pylori LPSs were bound by DC-SIGN 
(Fig. 4 and Appendix B). The strongest binding was detected to 26695 
and 14255 LPSs, likely associated with the high expression of Lex. This 
was confirmed by sequence-specific proteins and pointed by methyl-
ation analysis (Table 1 and Fig. 3). Binding with DC-SIGN observed to 
CI-117 and 14382 LPSs are likely to be due to Ley and H-type 2-contain-
ing sequences (Fig. 4 and Appendix B). 
Galectin-3 is a β-galactoside-binding lectin suggested to interact with 
H. pylori through the O-antigen side chain of LPS (Fowler, Thomas, 
Atherton, Roberts, & High, 2006). In contrast to the broad binding of 
DC-SIGN to all six H. pylori LPSs, galectin-3 showed a restricted binding 
to those from strains CI-117 and 14382 (Fig. 4). Consistent with previous 
reports (Gimeno et al., 2019; Hirabayashi et al., 2002; Sato & Hughes, 
1992; Stowell et al., 2008), galectin-3 bound to the non-fucosylated and 
fucosylated LacNAc-based sequence-defined NGL probes #8-#11, and 
#13, #14, respectively (Appendix B). Among these, the strongest 
binding was to H-type 1 (#13) and H-type 2 (#14)-related structures. 
Also, weak binding was detected to probe pLNFH-IV (#17, Appendix B), 
containing a Lex linked to a LacNAc disaccharide (LacNAc-Lex). Previous 
studies have shown weak binding of galectin-3 to Lex determinants (Sato 
& Hughes, 1992), while others have reported no binding to LacNA-
c-Lex-Lex structures using glycan microarrays (Stowell et al., 2008). 
These findings reinforce the preference of galectin-3 for internal 
unsubstituted LacNAc units within polyLacNAc and that the recognition 
of this lectin is not influenced by terminal modifications, but, may 
instead, be affected by internal polyLacNAc alterations (Feizi et al., 
1994; Gimeno et al., 2019). Considering the reported galectin-3 speci-
ficity and the microarray data above, the recognition of CI-117 and 
14382 LPSs by galectin-3 could be due to the presence of internal 
LacNAc sequences in the O-chain region of the LPS, as pointed by strong 
binding with DSL and anti-i P1A ELL1, as well as to H-type 1 and H-type 
2 sequences. Overall, CI-117 and 14382 LPSs showed similar patterns of 
glycan recognition with the proteins tested in the arrays (Fig. 4 and 
Appendix B). A striking difference seems to be related with terminal 
βGal residues, where binding with RCA120 was stronger to 14382 than 
CI-117 LPS (signal intensities: 25,366 and 3,711, respectively - Appen-
dix B). This reinforces the expression of a 3-galactan in 14382 LPS 
suggested by methylation analysis (Table 1). Although no prior work has 
been done on interaction between galectin-3 and the 3-galactan recently 
proposed to occur in another H. pylori LPS (Chandan et al., 2013), the 
ability of this lectin to recognize polygalactosyl repeats (Galβ1-3) on 
lipophosphoglycans of the parasite Leishmania major (Pelletier & Sato, 
2002), as well as the mammalian-like epitope Galα1-3 Gal on LPS 
O-antigen of the Gram-negative bacterium Providencia alcalifaciens 
(Stowell et al., 2014), supports this hypothesis. 
3.5. Application of H. pylori LPS microarray for exploring adaptive 
immunity 
Further to the interaction studies with host innate immune receptors, 
H. pylori LPS microarray was applied to investigate human serum IgG 
antibody responses to H. pylori LPSs, and to assess its utility for sero-
logical studies. A total of 24 serum samples were compared: 12 from 
H. pylori-infected (Hp+) individuals and 12 from non-infected (Hp-), 
grouped according to the clinicopathological parameters described in 
Table S2. 
A distinctive serum IgG antibody response pattern was observed with 
Hp + cases to H. pylori LPS compared to other bacterial LPS (Fig. 5a and 
b and Appendix B). Remarkably, serum from Hp + cases elicited strong 
antibody reactivity against LPSs of all H. pylori clinical isolates with the 
means of IgG detection levels being significantly higher in the Hp+
group compared to those of Hp- controls (Fig. 5a). This correlates with 
the results using a commercial anti-H. pylori ELISA kit (Fig. 5a), that 
measures the IgG levels using as antigen a lysate of the H. pylori strain 
ATCC 43504. Although a higher IgG reactivity of sera from Hp+ in-
dividuals was also observed towards the reference strain 26695 LPS, 
compared to that of Hp- controls, the difference of the means was not 
statistically significant (Fig. 5a). A possible reason is that, in contrast to 
the clinical isolates, the H. pylori 26695 is a laboratory-adapted strain 
that has been subjected to multiple sub-cultivations on artificial media 
and may have thereby evolved to have an LPS with altered glycosyla-
tion. The 26695 LPS is indeed striking in its lack of binding by galectin-3 
or weak binding to the LacNAc and polyLacNAc-binding proteins that 
are variously bound by the LPSs of the clinical isolates (Appendix B). 
Comparing the IgG reactivity of Hp+ and Hp- groups against other 
bacterial LPSs, likely due to the cross reactivity with other LPS antigens, 
no significant differences were observed (Fig. 5b). These results show 
that the IgG antibody responses detected with Hp+ sera are specific for 
structures present in the LPS of H. pylori clinical isolates that are highly 
immunogenic in humans (Pece et al., 1997). 
The occurrence of Lewis antigens in many H. pylori LPSs was previ-
ously suggested to elicit an autoimmune response in infected individuals 
(Appelmelk et al., 1996). However, other studies reported the absence of 
significant titers of antibodies to Lewis antigens in sera of 
H. pylori-infected individuals (Amano, Hayashi, Kubota, Fujii, & Yokota, 
1997). Instead, two distinct antigens (termed highly and weakly anti-
genic epitopes) were observed in the O-chain region of all H. pylori 
smooth-form LPS, by reactivity with sera from humans with natural 
infection (Yokota et al., 2000). Furthermore, IgG and IgA antibodies 
observed against rough-LPS, besides smooth-LPS of the H. pylori NCTC 
11637, indicated an immunogenic role of the core oligosaccharide (Pece 
et al., 1997) and reinforced previous findings that the antigenic epitopes 
in the LPS are unlikely to be immunologically associated with the Lewis 
antigen related structures (Amano et al., 1997; Yokota et al., 1998). 
In this work, IgG antibody reactivities were not detected in serum 
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from Hp+ individuals towards the fucosylated sequence-defined NGL 
probes (#13-#21, Appendix B), among them monomeric Lex, SLex, Lea, 
Leb and Ley, nor to other oligosaccharide sequences, such #11 and #12 
(i-antigen), that were included in the microarray, and that may be found 
in the H. pylori LPS O-chain (Appendix B). These results are in agreement 
with a previous study of sera from H. pylori-infected patients with gastric 
pathologies (Pece et al., 1997): IgG antibodies against long polymeric, 
repeating Lex antigen chains were detected, but not to short monomeric 
Lex antigen chains. Long, repeating Lex antigen chains were not included 
in this microarray. 
The utility of carbohydrate microarrays for antibody profiling 
against bacterial glycans with potential for serodiagnosis of bacterial 
infections is increasing (Campanero-Rhodes, Palma, Menendez, & Solis, 
2019). Our study clearly demonstrates the suitability of carbohydrate 
microarrays for serological studies, enabling detection of a specific 
anti-H. pylori LPS IgG response in sera from H. pylori-infected in-
dividuals. This microarray approach holds potential for rapid screening 
of multiple clinical samples to study host immune responses and to 
assess the seroprevalence of anti-LPS antibodies after the exposure to 
different H. pylori strains and to other bacteria. Furthermore, investi-
gation of serum responses triggered by different isotypes of immuno-
globulins against H. pylori LPSs would be valuable for associating 
clinical strains with different gastric diseases (Yokota et al., 1998). 
4. Conclusion 
The present study extends current knowledge on the chemical 
structures of H. pylori LPS by combining structural analysis and carbo-
hydrate microarray analyses with carbohydrate sequence-specific pro-
teins. All LPSs tested expressed Lewisx/y and N-acetyllactosamine 
determinants. Interestingly, ribans were detected in LPSs from all clin-
ical isolates, as distinct from the 26695 LPS. There was evidence for the 
presence of 1,3-D-galactans and the blood group H-type 2 sequence in 
two of the clinical isolates, the latter not yet reported for H. pylori LPS. 
The carbohydrate microarray analyses showed differences of LPSs of the 
studied H. pylori strains in their recognition by the immune lectins DC- 
SIGN and galectin-3. Furthermore, the sera from H. pylori-infected pa-
tients were shown to contain IgG antibodies to H. pylori LPSs that were 
distinct from those directed at LPSs from other bacteria, demonstrating 
the potential of the microarray approach for serological studies. This 
work paves the way to applying carbohydrate microarrays combined 
with methods of structural analysis in H. pylori research while expanding 
their contents to include well characterized LPS-derived fragments of 
H. pylori LPS isolated from patients with more severe clinical outcomes. 
This will provide further analytical insights into the H. pylori LPS 
composition and help elucidate clinically relevant immunogenic com-
ponents in these polysaccharides. The use of these complementary ap-
proaches will contribute to a better understanding of the molecular 
complexity of the LPSs and involvement in pathogenesis. 
CRediT authorship contribution statement 
Lisete M. Silva: Conceptualization, Data curation, Investigation, 
Formal analysis, Software, Validation, Project administration, Writing - 
original draft, Writing - review & editing. Viviana G. Correia: Data 
curation, Investigation, Software, Validation, Writing - review & editing. 
Ana S.P. Moreira: Investigation, Writing - review & editing. Maria 
Rosário M. Domingues: Writing - review & editing, Resources. Rui M. 
Ferreira: Resources, Writing - review & editing. Céu Figueiredo: Re-
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